Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer
Clinical trial NCT03662074 · TERMINATED
Trial details
- NCT number
- NCT03662074
- Sponsor
- Wake Forest University Health Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2020-10-07
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.